Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

University Of Central Lancashire To Deliver Nurtured Heart Workshop, UK
Residential childcare and fostering agency, Perpetual Care, and the University of Central Lancashire"s School of Nursing & Caring Sciences are jointly developing an introductory workshop on the ground-breaking Nurtured Heart Approach, which seeks to improve social and educational outcomes for many children and young people. Experts from UCLan and Perpetual are currently designing an awareness workshop, which will provide an overview of the approach, examine existing US research findings and explore its potential role in UK residential childcare and fostering, particularly in the light of revised NICE guidelines relating to children with ADHD. The first session is scheduled at UCLan"s Preston campus in late June this year and should be of interest to registered social workers, local authority placement officers and other social care and health professionals concerned with the well-being of challenging young people.
generic viagra online
Budesonide/formoterol Plus Tiotropium Improves The Quality Of Life Of Patients With Severe COPD
Preliminary results from a double-blind, randomised, multicentre trial among 660 patients with chronic obstructive pulmonary disease (COPD) show that budesonide/formoterol (Symbicort®: AstraZeneca) plus tiotropium (Spiriva™: Boehringer Ingelheim Limited) significantly improves disease control and patients" quality of life.1,2
News of the day
Combined Stem Cell Gene Therapy Approach Cures Human Genetic Disease In Vitro
A study led by researchers at the Salk Institute for Biological Studies, has catapulted the field of regenerative medicine significantly forward, proving in principle that a human genetic disease can be cured using a combination of gene therapy and induced pluripotent stem (iPS) cell technology. The study, published in the May 31, 2009 early online edition of Nature, is a major milestone on the path from the laboratory to the clinic.
Medical Devices

Saint Barnabas Medical Center Is Only Hospital In New Jersey To Offer Clinical Trial For The Treatment Of Recurrent Chest Wall Breast Cancer

Some patients who suffer from recurrent cancer at the chest wall now have another option. The Radiation Oncology Department at Saint Barnabas Medical Center is one of a few hospitals nationwide to participate in a study which combines the use of the heat-sensitive chemotherapeutic agent ThermoDox® with microwave hyperthermia, or heat. Depending on risk factors, a large percentage of women with mastectomies may experience recurrent chest wall (RCW) breast cancer. The disease is generally defined as the recurrence of tumor to the area of the initial treatment such as mastectomy. "ThermoDox® combined with hyperthermia offers a unique approach to treating patients with difficult and aggressive recurrence of breast cancer at the chest wall," explains Robert Goodman, M.D., chairman of The Radiation Oncology Department at Saint Barnabas Medical Center an co-principal investigator. "Currently, with no standard of care, women with this type of recurrence often cannot be adequately treated with surgery, radiation, or existing chemotherapy." The clinical trial, referred to as the DIGNITY Study, sponsored by Celsion Corporation [NASDAQ:CLSN], is designed to determine the necessary amount of ThermoDox® needed to treat RCW. Researchers hope such treatment will provide a better standard of care and improve the quality of life for those with the devastating disease. To learn more, please contact Dr. Goodman at 973-322-5630 or visit http://www.clinicaltrials.gov. Saint Barnabas Medical Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009